Anyone affected by internal bleeding after taking Pradaxa is urged to speak with a lawyer about their legal options as soon as possible.
Dallas, TX (PRWEB) January 15, 2013
The prescription drug resource center DrugRisk.com is alerting patients who have taken the blood thinner Pradaxa that new information has been added from the federal court overseeing litigation over alleged internal bleeding complications from the drug.
The goal of DrugRisk is to improve patient safety by providing the public with the latest drug warnings, recalls, studies and litigation news. Many consumers seek information on lawsuits to find out if others are experiencing similar problems and what options they have, explains DrugRisk representative Ryan Mayer.
Information on DrugRisk shows experts disagree about the safety of Pradaxa and its bleeding risks. While there has been no Pradaxa recall, the FDA recently issued an update that the drug carries the same risks as warfarin.* However, the American College of Cardiology has warned that Pradaxa use can significantly increase the risk of bleeding complications compared to warfarin.**
Due to the number of Pradaxa lawsuits filed, DrugRisk has learned that the cases have been moved to a special federal court in Illinois, formally known as MDL No. 2385, IN RE: Pradaxa Product Liability Litigation, Southern District of Illinois.
Now, the resource center has added an update from Judge David Herndon stating that, with 176 cases filed, the parties are producing tens of thousands of pages of evidence and lawyers for victims will soon start taking deposition testimony from members of Boehringer Ingelheim, who makes the drug.***
Anyone affected by internal bleeding after taking Pradaxa is urged to speak with a lawyer about their legal options as soon as possible. Due to the specialized nature of federal drug injury cases, the Drug Risk Resource Center only recommends lawyers who are already handling Pradaxa lawsuits.
For more information on the research, side effects and litigation news related to Pradaxa and other drugs, or to speak with a lawyer, visit http://www.DrugRisk.com.